ArticleWorld journal of gastroenterology2023

Potential therapeutic targets for nonalcoholic fatty liver disease: Glucagon-like peptide 1.

Yue-Hua Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.